2014 10 30

4.41

2014 10 20 12

12

1,744 381 2

1,744 381 2

104 1 296,026 1,744

3 1

3
1


2007

2011

3
4
4

Lee 2012, Mark 2012

100%
100%

100%

100%

100%
prevalence

1Sox 1988

1
P()

P()

P()

100

P()
P()()

 P(
) 100%
P()()
1
1 P(
) 0%

test
sign
X CT

symptom

22

22=4 22
33

(
2013)

Gold Standard

100%

5 6

22

22

Gold Standard

22 1

22

22

22

Gordis 2014

1 2
2
5
4

 18 1
20.1mm 5.1mm B C
22

()

()

18 1
20.1mm 5.1mm B C
2

22

()

22

()

()

22

()

()

()

22

()

()

(
)

22

()
9


22 12

22 7

1,744 381 2

104 1
296,026 1,744
1,791

18 1
20.1mm 5.1mm B C
10

22

1,848

294,178

296,026

18 1
20.1mm 5.1mm B C
22

485

1,363

1,848

294,178

296,026

18 1
20.1mm 5.1mm B C
2

22

104

381

485

1,363

1,848

22

58

46

104

381

485

11

22

57

58

46 *

104

*104 2 44

22

58

57 104

22

57 104

12

Gold Standard

1 103
103
1

13

Gordis L: Chap.5. Assessing the validity and reliability of diagnostic and screening tests.
In: Epidemiology. 5th ed., Elsevier Saunders, Amsterdam, 2014, pp.88-115.
Lee TH: Chap. 9 Using data for clinical decisions.

In: Goldmans Cecil internal

medicine. Goldman L. Schafer A.I., et al. eds., Elsevier Saunders, Amsterdam, 2012,
pp. 32-37.
Mark DB, and Wong JB: Chap. 3 Decision-making in clinical medicine. In:Harrisons
principles of internal medicine. 18th ed. Longo DL et al. eds. McGraw Hill Medical, New
York, 2012, pp.19-28.
Sox HC: Medical decision making. Butterworths, 1988.
( 1458)2013

14